GL1X · GenesisL1 explorer

Ligand · VX1

VX1 · 4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine

VX1, 4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine (C17 H11 Cl N4 O, 322.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it…

Component
VX1
Formula
C17 H11 Cl N4 O
Class
ligand
Structures
2
PDB entries
1

Binding sites

VX1 in 2 structures; the first of them:

  • 3BGP · Human Pim-1 complexed with a benzoisoxazole inhibitor VX1 · VX1 A314 · binds LEU44, PHE49, VAL52, ALA65, LYS67, GLU89, ILE104, LEU120 and 9 more
  • 3BGP · Human pim-1 complexed with a benzoisoxazole inhibitor VX1 · VX1 A314 · binds LEU44, PHE49, VAL52, ALA65, LYS67, GLU89, ILE104, LEU120 and 9 more

Residues it binds most

ASP 2, LEU 2, GLU 2, ILE 2, VAL 2, ALA 2, ARG 2, LYS 2, PHE 2, PRO 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.